# SERPINF2

## Overview
SERPINF2 is a gene that encodes the protein serpin family F member 2, commonly known as alpha-2 antiplasmin. This protein is a member of the serpin superfamily, which is characterized by its role as a serine protease inhibitor. Alpha-2 antiplasmin plays a critical role in the regulation of fibrinolysis, the process of breaking down blood clots, by inhibiting plasmin, a key enzyme responsible for fibrin degradation. The protein's structure, which includes a conserved serpin domain, facilitates its function in maintaining hemostatic balance by preventing excessive clot breakdown. Beyond its primary role in the circulatory system, SERPINF2 is also involved in various biological processes, including blood coagulation and inflammation, and has been implicated in neurodegenerative diseases under certain pathological conditions (Silverman2001The; Chen2019Cloning; Zattoni2022Serpin).

## Structure
SERPINF2, also known as alpha-2 antiplasmin, is a serine protease inhibitor involved in inhibiting fibrinolysis. The primary structure of SERPINF2 consists of a sequence of amino acids forming the polypeptide chain. Its secondary structure includes alpha helices and beta sheets, which are typical features of serpin proteins (Silverman2001The). The tertiary structure of SERPINF2 is characterized by a conserved serpin domain, which includes three beta-sheets and 7-9 alpha-helices, allowing it to interact with target proteases like plasmin (Chen2019Cloning). This structure facilitates the 'suicide' inhibitory mechanism, where the reactive center loop (RCL) is cleaved by the target protease, leading to a conformational change that inactivates the protease (Silverman2001The).

Post-translational modifications of SERPINF2 may include glycosylation, which can affect its stability and function. The presence of splice variants may result in different isoforms with distinct functional properties, although specific details on these variants are not provided in the context. The protein's ability to form complexes with other molecules or proteins is part of its quaternary structure, which is crucial for its role in fibrinolysis inhibition (Zattoni2022Serpin).

## Function
SERPINF2, also known as alpha-2 antiplasmin, is a crucial protein in the regulation of fibrinolysis, the process responsible for breaking down blood clots. It functions primarily as an inhibitor of plasmin, a serine protease that degrades fibrin clots, thereby maintaining clot stability and preventing excessive bleeding (Chen2019Cloning; Zattoni2022Serpin). This protein is predominantly active in the bloodstream, where it plays a vital role in hemostasis, ensuring that blood clots are adequately formed and maintained to prevent hemorrhage (Li2005Detecting).

In healthy human cells, SERPINF2 is involved in various biological processes beyond fibrinolysis, including blood coagulation and inflammation. It is part of the serpin superfamily, which includes proteins that modulate proteolytic networks essential for maintaining vascular integrity and function (TombranTink2005The). The protein's activity is crucial for balancing coagulation and anticoagulation processes, thereby contributing to blood homeostasis (Chen2019Cloning). While SERPINF2 is not typically expressed at high levels in the brain, its expression can be induced under certain pathological conditions, suggesting a potential role in neurodegenerative diseases (Zattoni2022Serpin).

## Clinical Significance
Mutations in the SERPINF2 gene, which encodes the alpha-2 antiplasmin protein, can lead to alpha-2 antiplasmin deficiency, a condition characterized by a severe hemorrhagic tendency due to impaired regulation of fibrinolysis. This deficiency results in excessive bleeding, as the lack of functional alpha-2 antiplasmin allows unregulated plasmin activity, leading to rapid clot breakdown (Favier2001Congenital; Aoki1979Congenital). The condition is often inherited in an autosomal recessive manner, with homozygous individuals experiencing severe bleeding symptoms from a young age, such as hemarthrosis and prolonged bleeding after minor trauma (Favier2001Congenital).

Specific mutations in SERPINF2, such as a homozygous nonsense mutation leading to a premature termination codon, have been identified in patients with severe plasmin inhibitor deficiency. These mutations result in significantly reduced levels of plasmin inhibitor antigen and activity, contributing to the bleeding disorder (Pozzi2019May). The clinical presentation of alpha-2 antiplasmin deficiency can include prolonged bleeding from lacerations, poor wound healing, and other severe bleeding symptoms (Egan2019Abnormal). Treatment with lysine analogues like tranexamic acid can be effective in managing the condition by inhibiting plasminogen activation (Egan2019Abnormal).

## Interactions
SERPINF2, also known as alpha-2 antiplasmin, is a serine protease inhibitor that primarily interacts with plasmin, a key enzyme in the fibrinolytic system. By inhibiting plasmin, SERPINF2 prevents the excessive breakdown of fibrin clots, thereby playing a crucial role in maintaining hemostatic balance (Law2006Anoverviewoftheserpinsuperfamily). This interaction is significant in the context of both coagulation and fibrinolysis, as SERPINF2 forms complexes with plasminogen and fibrin, stabilizing clots and modulating the fibrinolytic system (Law2006Anoverviewoftheserpinsuperfamily).

In addition to its role in fibrinolysis, SERPINF2 has been implicated in neurodegenerative diseases. In prion-infected mouse brains, SERPINF2 is significantly upregulated, suggesting a potential interaction with components involved in neurodegeneration. This upregulation may represent a cellular response to mitigate plasmin activity, which could otherwise contribute to the degradation of extracellular protein aggregates, favoring the accumulation of misfolded proteins (Zattoni2022Serpin).

Despite its critical functions, predicting interactions involving SERPINF2 remains challenging due to its uncorrelated expression patterns with its target proteases, such as kallikreins, across different tissues (Fortelny2017ProteaseInhibitor).


## References


[1. (TombranTink2005The) Joyce Tombran-Tink. The neuroprotective and angiogenesis inhibitory serpin, pedf: new insights into phylogeny, function, and signaling. Frontiers in Bioscience, 10(1–3):2131, 2005. URL: http://dx.doi.org/10.2741/1686, doi:10.2741/1686. This article has 67 citations and is from a peer-reviewed journal.](https://doi.org/10.2741/1686)

[2. (Law2006Anoverviewoftheserpinsuperfamily) Ruby HP Law, Qingwei Zhang, Sheena McGowan, Ashley M Buckle, Gary A Silverman, Wilson Wong, Carlos J Rosado, Chris G Langendorf, Rob N Pike, Philip I Bird, and James C Whisstock. An overview of the serpin superfamily. Genome Biology, 7(5):216, 2006. URL: http://dx.doi.org/10.1186/gb-2006-7-5-216, doi:10.1186/gb-2006-7-5-216. This article has 887 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/gb-2006-7-5-216)

[3. (Pozzi2019May) Loris Pozzi, Patrizia Della Valle, and Armando D’Angelo. May restricted specificity of commercially available plasmin inhibitor activity assays affect correct diagnosis of antiplasmin deficiency? Blood Coagulation &amp; Fibrinolysis, 30(1):52–53, January 2019. URL: http://dx.doi.org/10.1097/mbc.0000000000000788, doi:10.1097/mbc.0000000000000788. This article has 3 citations.](https://doi.org/10.1097/mbc.0000000000000788)

[4. (Chen2019Cloning) Liangming Chen, Rong Huang, Denghui Zhu, Yumeng Wang, Rumana Mehjabin, Yongming Li, Lanjie Liao, Libo He, Zuoyan Zhu, and Yaping Wang. Cloning of six serpin genes and their responses to gcrv infection in grass carp (ctenopharyngodon idella). Fish &amp; Shellfish Immunology, 86:93–100, March 2019. URL: http://dx.doi.org/10.1016/j.fsi.2018.11.008, doi:10.1016/j.fsi.2018.11.008. This article has 11 citations.](https://doi.org/10.1016/j.fsi.2018.11.008)

[5. (Zattoni2022Serpin) Marco Zattoni, Marika Mearelli, Silvia Vanni, Arianna Colini Baldeschi, Thanh Hoa Tran, Chiara Ferracin, Marcella Catania, Fabio Moda, Giuseppe Di Fede, Giorgio Giaccone, Fabrizio Tagliavini, Gianluigi Zanusso, James W. Ironside, Isidre Ferrer, and Giuseppe Legname. Serpin signatures in prion and alzheimer’s diseases. Molecular Neurobiology, 59(6):3778–3799, April 2022. URL: http://dx.doi.org/10.1007/s12035-022-02817-3, doi:10.1007/s12035-022-02817-3. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12035-022-02817-3)

[6. (Favier2001Congenital) R. Favier, N. Aoki, and P. De Moerloose. Congenital α2‐plasmin inhibitor deficiencies: a review. British Journal of Haematology, 114(1):4–10, July 2001. URL: http://dx.doi.org/10.1046/j.1365-2141.2001.02845.x, doi:10.1046/j.1365-2141.2001.02845.x. This article has 71 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1046/j.1365-2141.2001.02845.x)

[7. (Aoki1979Congenital) Nobuo Aoki, Hidehiko Saito, Tadashi Kamiya, Katsuo Koie, Yoichi Sakata, and Masateru Kobakura. Congenital deficiency of α2-plasmin inhibitor associated with severe hemorrhagic tendency *. Journal of Clinical Investigation, 63(5):877–884, May 1979. URL: http://dx.doi.org/10.1172/jci109387, doi:10.1172/jci109387. This article has 146 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci109387)

[8. (Silverman2001The) Gary A. Silverman, Phillip I. Bird, Robin W. Carrell, Frank C. Church, Paul B. Coughlin, Peter G.W. Gettins, James A Irving, David A. Lomas, Cliff J. Luke, Richard W. Moyer, Philip A. Pemberton, Eileen Remold-O’Donnell, Guy S. Salvesen, James Travis, and James C. Whisstock. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Journal of Biological Chemistry, 276(36):33293–33296, September 2001. URL: http://dx.doi.org/10.1074/jbc.r100016200, doi:10.1074/jbc.r100016200. This article has 964 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.r100016200)

[9. (Fortelny2017ProteaseInhibitor) Nikolaus Fortelny, Georgina S. Butler, Christopher M. Overall, and Paul Pavlidis. Protease-inhibitor interaction predictions: lessons on the complexity of protein–protein interactions. Molecular &amp; Cellular Proteomics, 16(6):1038–1051, June 2017. URL: http://dx.doi.org/10.1074/mcp.m116.065706, doi:10.1074/mcp.m116.065706. This article has 17 citations.](https://doi.org/10.1074/mcp.m116.065706)

[10. (Egan2019Abnormal) Grace Egan, Fred G. Pluthero, Vanessa Bouskill, Pamela Hilliard, Luke J. Drury, Manuel D. Carcao, and Walter H. A. Kahr. Abnormal fibrinolysis recognized by thromboelastography in a case of severe bleeding with normal coagulation and platelet function, leads to detection of a novel serpinf2 variant causing severe alpha‐2‐antiplasmin deficiency. British Journal of Haematology, July 2019. URL: http://dx.doi.org/10.1111/bjh.16077, doi:10.1111/bjh.16077. This article has 2 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1111/bjh.16077)

[11. (Li2005Detecting) Zuofeng Li, Qi Liu, Mangen Song, Ying Zheng, Peng Nan, Ying Cao, Guoqiang Chen, Yixue Li, and Yang Zhong. Detecting correlation between sequence and expression divergences in a comparative analysis of human serpin genes. Biosystems, 82(3):226–234, December 2005. URL: http://dx.doi.org/10.1016/j.biosystems.2005.07.004, doi:10.1016/j.biosystems.2005.07.004. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.biosystems.2005.07.004)